Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome
DNA Demethylation
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).
Unconventional myosin traffic in cells reveals a selective actin cytoskeleton.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma. Leukemia. 2019 09; 33(9):2324-2330.
View in:
PubMed
subject areas
Exome
Exosome Multienzyme Ribonuclease Complex
Female
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Multiple Myeloma
Pedigree
authors with profiles
Siwei Chen